ALT/SGPT

Activated partial thromboplatin time (aPTT) Adrenocorticotropic hormone (ACTH) Alanine aminotransferase (ALT, SGPT) Albumin... [Pg.1545]

Blood glucose, liver enzymes, and serum alkaline phosphatase, bilirubin, and potassium, AST (SCOT), and ALT (SGPT) levels... [Pg.386]

Liver function tests Serum ALT (SGPT) levels taken at baseline and every 2 weeks... [Pg.357]

Must monitor serum ALT (SGPT) levels every 2 weeks for the duration of treatment... [Pg.358]

Pemoline should be discontinued if serum ALT (SGPT) is increased to a clinically significant level, if any increase >2 times the upper limit of normal occurs, or if clinical signs and symptoms suggest liver failure... [Pg.358]

Pemoline should be discontinued if serum ALT (SGPT) increases to t A/ice the normal upper limit... [Pg.359]

Patients who discontinue treatment with tacrine because of ALT/SGPT elevation may be rechallenged with an initial dose ot 40 mg 4 times per day maintained for 6 weeks before titration... [Pg.441]

Treatment should be discontinued if ALT (SGPT) exceeds the upper limit of normal or clinical signs of hepatic failure occur. [Pg.220]

One patient developed mild liver toxicity, but the liver function normalised without the discontinuation of anidulafungin. The AST/SCOT and ALT/SGPT levels decreased during treatment. No significant changes were observed in alkaline phosphatase, GGT or bilirubin levels. Similarly, serum creatinine levels were reduced during anidulafungin administration. [Pg.388]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...